[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@doctorvasan Red-pilled Rebel
Red-pilled Rebel posts on X about $nams, amsterdam, the only, behind the the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX -XX%
- X Month XXXXX +613%
- X Months XXXXX -XX%
- X Year XXXXXX -XX%
Mentions: X #
- X Week XX -XX%
- X Month XX +70%
- X Months XX +71%
- X Year XXX -XXXX%
Followers: XXXXX #
- X Week XXXXX +0.13%
- X Month XXXXX +1.30%
- X Months XXXXX +6.70%
- X Year XXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence travel destinations
Social topic influence $nams #2, amsterdam, the only, behind the, phd, bp, has been
Top assets mentioned NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
Top Social Posts #
Top posts by engagements in the last XX hours
"VESALIUS-CV results provided a boost to $NAMS by providing evidence for lower (ldlc) the better hypothesis & providing impetus to multi (3) drug oral formulation. Furthermore it raises pressure for a early PREVAIL readout (as participants cant take PCSK9i) & approval of Obi"
X Link @doctorvasan 2025-10-06T14:12Z 1494 followers, XXX engagements
"The chart explains how $NAMS Obicetrapib fares against other lipid lowering drugs. In combination with Ezetimibe its ldlc/Lpa effect gets amplified by another 40%"
X Link @doctorvasan 2025-10-14T00:00Z 1494 followers, XXX engagements
"CETPI Obicetrapib $NAMS is the only LLD that preferentially decimates sdLDL by an astounding 97%. Statins & PCSK9I reduce both sdLDL & lbLDL. This with up to XX% reduction in Lp(a) improved HbA1c & AD risk reduction makes it an attractive option once rolled out"
X Link @doctorvasan 2025-10-09T15:22Z 1494 followers, XXX engagements
"Statins remain first-line but up to XX% of them need add-on or alternative options as they dont tolerate it. CETPI 💊 Obicetrapib from $NAMS likely to fill the void. It also shows AD Lp(a) selective sdLDL HbA1c/Metabolic & BP benefits. It even amplifies GLP1A effects 🚀"
X Link @doctorvasan 2025-10-12T12:57Z 1494 followers, XXX engagements
"Wow Unlike Cleerly (the most common AI platform for CCTA imaging for CAD in the US) UK based Caristo measures vascular inflammation (that predates plaque build up) as well. Obis anti-inflammatory potency will be showcased along with plaque prevention. First for a LLD $NAMS"
X Link @doctorvasan 2025-10-14T14:51Z 1494 followers, XXX engagements
"$NAMS 🚀 is looking beyond CETPI Obicetrapib eyes new targets/Opportunities for CV disease program. Success of REMBRANDT Trial is key for quick concept to comercializaton in the future"
X Link @doctorvasan 2025-10-11T16:31Z 1494 followers, XXX engagements